Indications
Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Composition
- Active substance
- metaflumizone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- ProMeris
- Active substance
- metaflumizone
- Group
- Veterinary medicines
- Marketing authorisation holder
- Pfizer Limited
- Status
- Withdrawn
- EU authorisation
- 19 Dec 2006
- EMA product number
- EMEA/V/C/000107